![](https://investorshub.advfn.com/uicon/158678.png?cb=1661594561)
Thursday, November 13, 2014 5:56:59 PM
I assume that you are referring to this:
http://ih.advfn.com/p.php?pid=nmona&article=64392659
He didn't add them so much as he collected them. Instead of expressing appreciation for an investment he didn't make, one might give some thought to why the company struck a deal to borrow $4 million that, while costing it a reasonable 8% in cash interest, also appears to have cost them $1.5 million in "additional interest" in the form of shares since the time the loan was extended 20-21 months ago. An additional $2 million in debentures were issued at the time which presumably resulted in the issuance of an additional $.5 million in shares issued (plus the 8% coupon).
This is an extraordinary return to the investors and cost to shareholders...assuming that I understand it correctly...yet no one responded to the post that reported it earlier today.
The debenture calls for additional interest in the form of shares above and beyond those that have already been issued. I encourage you, or ANYONE, to try to reconcile the terms of the debenture as reported here.....
http://www.sec.gov/Archives/edgar/data/1379006/000114420413005490/v333720_8k.htm
.....with the Form 4 that was filed yesterday to see 1) how it was calculated and 2) whether the agreement was reasonable in terms of being in the interest of all NNVC shareholders.
"I ated the purple berries"
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM